SCHEMBL4920004

SCHEMBL4920004

COc1ccc(Cl)cc1Nc1nc(C)c(C(=O)O)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.55
POLB P06746 2/20 0.55
TP53 P04637 1/20 0.55
ALDH1A1 P00352 12/20 0.55
MEN1 O00255 10/20 0.55
KMT2A Q03164 10/20 0.55
CFTR P13569 5/20 0.55
LMNA P02545 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HTT P42858 2/20 0.55
NR2F2 P24468 1/20 0.55
HPGD P15428 7/20 0.55
KDM4E B2RXH2 6/20 0.55
ALB P02768 1/20 0.55
MAPK1 P28482 1/20 0.53
USP2 O75604 1/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPSR1 Q6W5P4 1/20 0.49
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3793912 0.91 ALDH1A1 (0.57) MAPTPOLBTP53ALDH1A1MEN1
SCHEMBL4923310 0.88 MAPT (0.57) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL4923308 0.88 MAPT (0.57) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL3798208 0.86 MAPT (0.52) MAPTPOLBTP53ALDH1A1MEN1
SCHEMBL4924626 0.83 MAPT (0.76) MAPTALDH1A1MEN1KMT2ACFTR
SCHEMBL4918908 0.81 MAPT (0.57) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL14214491 0.79 ANO1 (0.52) MAPTPOLBALDH1A1MEN1KMT2A
SCHEMBL14184625 0.78 MEN1 (0.61) MAPTPOLBTP53ALDH1A1MEN1
SCHEMBL4915995 0.77 MEN1 (0.58) MAPTPOLBALDH1A1MEN1KMT2A
SCHEMBL4923649 0.77 SMN1; SMN2 (0.59) MAPTPOLBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US claimed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP claimed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO claimed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
EP-1819330-A1 5-CARBOXAMIDO SUBSTITUED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY Devgen N.V. (BE) 2007-08-22 EP disclosed
WO-2006058905-A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY DEVGEN NV (BE) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 MAPT 1729/4885POLB 4818/4885TP53 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.